From the Journals
Obesity triples post-MI sudden cardiac death risk
The obesity paradox makes a showing in the risk of all-cause death.
From the Journals
New look at ATLAS suggests rivaroxaban may still have role in ACS
A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.
Conference Coverage
Amplatzer Amulet slashes stroke risk in A-fib
PARIS – “Given the high bleeding risk, single antiplatelet therapy seems to be a good option for these patients,” said Dr. Ulf Landmesser.
Conference Coverage
Design limitations may have compromised DVT intervention trial
WASHINGTON – The preferred evaluation – intravascular ultrasound – was not used.
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
Conference Coverage
Does warfarin cause acute kidney injury?
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
From the Journals
Women’s representation in CV drug trials still lagging
We’ve come a long way in clinical trial representation of women, but there’s more work to do.
Conference Coverage
MI before age 50? Think familial hypercholesterolemia, substance abuse
More than one-third of patients with an MI before age 50 and an LDL cholesterol of at least 160 mg/dL meet criteria for FH.
Conference Coverage
Impaired kidney function no problem for dabigatran reversal
ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.
Conference Coverage
VTE risk after bariatric surgery should be assessed
SEATTLE – Thromboelastometry can play a role in identifying bariatric surgery patients at risk for VTE.
Video
VIDEO: Screening ECG patch boosts AF diagnoses ninefold
ECG patches may provide an inexpensive and noninvasive way to screen for asymptomatic atrial fibrillation in high-risk people.
Conference Coverage
Few acutely ill hospitalized patients receive VTE prophylaxis
The results “imply that there is a significantly unmet need for effective VTE prophylaxis in both the inpatient and outpatient continuum of care...
Conference Coverage
ODYSSEY Outcomes trial redefines secondary cardiovascular prevention
ORLANDO – “I believe this trial is going to change practice.” – Valentin Fuster, MD
Video
Post-ACS death lowered in ODYSSEY Outcomes
ORLANDO – Mortality and major adverse cardiovascular events were cut 15%, but that’s not all.
Conference Coverage
Young diabetics are at sevenfold increased risk of sudden cardiac death
ANAHEIM, CALIF. – Danish national study is the first of its kind and found fivefold increased all-cause mortality.
Conference Coverage
Sex-triggered sudden cardiac arrest extremely rare
"Our take home message from this study is that sexual activity can be regarded as safe, even in cardiac patients."
From the Journals
Overweight and obese individuals face greater cardiovascular morbidity
Obese people have shorter life spans and spend more of their lives dealing with cardiovascular disease.
News
Thrombectomy’s success treating strokes prompts rethinking of selection criteria
very low number needed to treat for acute ischemic stroke patients to benefit from thrombectomy peaks interest in widening the treatment...
Conference Coverage
JAK inhibitors for RA: Is VTE risk overblown?
MAUI, HAWAII – “Certainly we are seeing these events. The question is, ‘How overdone is this?’ ” said Mark C. Genovese, MD.
Conference Coverage
EMS stroke field triage improves outcomes
EMS transfer of large-vessel stroke patients to a comprehensive stroke center led to quicker treatment, even when a primary stroke center was...
